SynthesisReviews in medical virology2020
Three months of COVID-19: A systematic review and meta-analysis.
Synthesis in Reviews in medical virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19.Journal of infection and public health · 2021Pooled it
- Magnitude of asymptomatic COVID-19 cases throughout the course of infection: A systematic review and meta-analysis.PloS one · 2021Pooled it
- Three months of COVID-19: A systematic review and meta-analysis.Reviews in medical virology · 2020Pooled it
- Comparative estimation of the spread of acute diarrhea and dengue in India using statistical mathematical and deep learning models.Scientific reports · 2025Article
- Article
- Severe acute respiratory illness surveillance for influenza in Kenya: Patient characteristics and lessons learnt.Influenza and other respiratory viruses · 2022Article
- What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?Current oncology reports · 2022Review
- The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses.Reviews in the neurosciences · 2022Review
- Maternal Anxiety and Its Associated Factors During the First and Second Wave of COVID-19 Pandemic in Serbia: A Cross-Sectional Study.Psychology research and behavior management · 2022Article
- Repurposing of Doxycycline to Hinder the Viral Replication of SARS-CoV-2: FromFrontiers in microbiology · 2022Article
- Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021Observational
- SIRVD-DL: A COVID-19 deep learning prediction model based on time-dependent SIRVD.Computers in biology and medicine · 2021Article
- Classical and Counter-Regulatory Renin-Angiotensin System: Potential Key Roles in COVID-19 Pathophysiology.CJC open · 2021Review
- Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.Reviews in medical virology · 2021Review
- Impact of essential workers in the context of social distancing for epidemic control.PloS one · 2021Article
- Psychological Stress Risk Factors, Concerns and Mental Health Support Among Health Care Workers in Vietnam During the Coronavirus Disease 2019 (COVID-19) Outbreak.Frontiers in public health · 2021Article
- Observational study of the suspected or confirmed cases of sars COV-2 infection needing emergency surgical intervention during the first months of the pandemic in a third level hospital: Case series.Annals of medicine and surgery (2012) · 2020Article
- Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules.Molecules (Basel, Switzerland) · 2020Review
- Evaluation and prediction of COVID-19 in India: A case study of worst hit states.Chaos, solitons, and fractals · 2020Article
- Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.Biochemical pharmacology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The pandemic of 2019 novel coronavirus (SARS-CoV-2019), reminiscent of the 2002-SARS-CoV outbreak, has completely isolated countries, disrupted health systems and partially paralyzed international trade and travel. In order to be better equipped to anticipate transmission of this virus to new regions, it is imperative to track the progress of the virus over time. This review analyses information on progression of the pandemic in the past 3 months and systematically discusses the characteristics of SARS-CoV-2019 virus including its epidemiologic, pathophysiologic, and clinical manifestations. Furthermore, the review also encompasses some recently proposed conceptual models that estimate the spread of this disease based on the basic reproductive number for better prevention and control procedures. Finally, we shed light on how the virus has endangered the global economy, impacting it both from the supply and demand side.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.